Page 2 - Warner Lambert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The full senate for final consideration. Steve liesman reported last week senator rand paul said he was thinking of putting a hold on yellens nomination unless a voet vote was loud on his proposal for more transparency on the fed. Beyond the fed, there are some other economic happenings. Namely, at 8 30 eastern time, we have two reports delayed by the Government Shutdown. First, we go the Consumer Price index. We also get retail sales. At 9 00, we have the s p caseshiller home price index. At 10 00, we get business inventories and Consumer Confidence. As fort corporate news, pfizer, etna, arch...

Ryanair with shares following suit. Youre watching Worldwide Exchange. Bringing you Business News from around the globe. Hello and a warm welcome to the first Worldwide Exchange of a fresh week here on cnbc. And its a lot of company news this morning. A lot of it is surrounding the activity of capital heights. We kickoff with astrazeneca who sped up their bid to pfizer. A fourth bid from pfizer rejected this morning. Astra said they would take 58 pounds per share. Pfizers offer was 55 pounds a share. Astrazenecas stock was off 14 . There you can see it down 48 pounds. 38 pounds was where we we...

Chips to Technology Stocks grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer...

Chips to Technology Stocks grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer...

Grabbed investors attention. All that and more tonight on nightly Business Report for monday, april 28th. Good evening, everyone. 100 billion. Thats what pfizer is offering to pay for astrazeneca. This is the Second Time Around pfizer is pushing for a deal with its british rival. Investors are cheering. Sending the dow soaring. Shares of pfizer shot up more than 4 by far the biggest gainer in the dow and astrazeneca jumped 12 . While the pharmaceutical deal may be huge its not a done deal. Astrazeneca has already rejected the offer and an earlier approach from pfizer saying the 100 billion cas...